Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

525
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
525
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

375
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Relative Risk01:12

Relative Risk

1.7K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active monitoring versus surgical excision for atypical ductal hyperplasia.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

The Impact of Breast Reconstruction on Smoking Cessation Among Patients With Breast Cancer.

Journal of surgical oncology·2026
Same author

Organisational learning and the evolution of ischaemic stroke care in a resource-constrained public hospital: a seven-year case study.

BMC health services research·2026
Same author

Survival Outcomes of Cabazitaxel or Subsequent Androgen Receptor Pathway Inhibitor (ARPI) in Post-Docetaxel/ARPI Metastatic Castration-Resistant Prostate Cancer.

Clinical genitourinary cancer·2026
Same author

Metagenomic characterization of the tracheobronchial microbiome in lung cancer.

Frontiers in microbiomes·2026
Same author

Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correlations Between the Histologic Growth Patterns of Peritoneal and Liver Metastases From Colorectal Cancer.

Annals of surgical oncology·2026
Same journal

Long-term Outcomes of Surgery for Clinical T4 Non-Small Cell Lung Cancer: Implications for Surgical Decision Making in the TNM 9th Edition Era.

Annals of surgical oncology·2026
Same journal

Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.

Annals of surgical oncology·2026
Same journal

ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder Cancer.

Annals of surgical oncology·2026
Same journal

Intraoperative Radiotherapy for Breast Cancer: Long-Term Experience.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Factors Associated with Omission of Axillary Lymph Node Dissection for Patients with Clinical Node-Positive Breast Cancer who have Residual Nodal Disease on Pathology After Neoadjuvant Chemotherapy.

Annals of surgical oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk Assessment.

Melissa Rangel1, Shirlene Paul1, Dipti Gupta1

  • 1Rush University Medical Center, Chicago, IL, USA.

Annals of Surgical Oncology
|October 26, 2025
PubMed
Summary
This summary is machine-generated.

The Gail Model underestimates breast cancer risk for Black women. Despite similar diagnosis rates, Black women are less likely to be classified as high-risk (HR) by the model compared to White women.

Keywords:
DisparityGail modelRaceRisk calculator

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

616

Related Experiment Videos

Last Updated: Jan 6, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

616

Area of Science:

  • Medical informatics
  • Public health
  • Epidemiology

Background:

  • The Gail Model, a breast cancer risk assessment tool, was initially developed on data from predominantly White women.
  • Despite recalibrations with diverse populations, concerns persist about underestimating breast cancer risk in certain racial groups.

Purpose of the Study:

  • To evaluate the performance of the Gail Model in classifying breast cancer risk across different racial groups.
  • To identify potential racial disparities in high-risk (HR) classification.

Main Methods:

  • A retrospective study analyzed electronic medical records of 31,256 women aged 25-75 who underwent mammograms.
  • The cohort comprised diverse racial groups: 11,589 Black/African American, 11,008 White, 5,872 Hispanic/Latino, 1,429 Asian, and 1,358 other.

Main Results:

  • Significant differences in high-risk (HR) classification were observed across racial groups.
  • White women had the highest HR classification rate (11.4%).
  • Black women had a significantly lower odds ratio (OR = 0.23) for HR classification compared to White women, even after controlling for other variables. Breast cancer diagnosis rates were similar between Black (1.57%) and White (1.6%) women.

Conclusions:

  • The Gail Model demonstrates racial disparity in high-risk classification.
  • Black women are less likely to be identified as high-risk, despite comparable cancer incidence rates to White women.
  • This highlights potential limitations of race-based variables in risk assessment algorithms.